Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/897c1421d763409b9b5cd4b0353c9706 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|